| Group A (CT-MRTA-3D-MFI) | Group B (CTA/V-DTT-3D-MFI) | P value |
---|---|---|---|
Sex(male/fmale) | 18/22 | 17/23 | 0.822 |
Mean age(y) | 48.1 ± 11.9 | 48.5 ± 12.5 | 0.251 |
Symptomatic side(L/R) | 16/24 | 21/19 | 0.262 |
SPV injuries (case) | 11/29 | 4/36 | 0.045 |
Surgery time (min) | 95.7 ± 3.2 | 85.9 ± 2.1 | 0.000 |
Intraoperative hemorrhage(ml) | 40.3 ± 8.2 | 22.5 ± 5.8 | 0.000 |
TN-Outcome | Â | Â | Â |
I | 12 | 18 | - |
II | 7 | 3 | - |
III | 2 | 0 | 0.035 |
TN -Complications | Â | Â | Â |
Vertigo | 9 | 5 | - |
Perioral herpes | 7 | 3 | - |
Facial numbness | 3 | 1 | 0.026 |
Recurrence(one-year) | 4(19%) | 2(9.5%) | - |
HFS-Outcome | Â | Â | Â |
I | 14 | 16 | - |
II | 4 | 3 | - |
III | 1 | 0 | 0.398 |
HFS -Complications | Â | Â | Â |
Vertigo | 10 | 5 | - |
Perioral herpes | 5 | 3 | - |
Facial numbness | 3 | 0 | - |
Tinnitus | 1 | 0 | 0.008 |
Recurrence(one-year) | 3 (7.9%) | 1 (5.3%) | - |